Light at the ENDothelium-role of Sox17 and Runx1 in endothelial dysfunction and pulmonary arterial hypertension
Pulmonary arterial hypertension (PAH) is a progressive disease that is characterized by an obliterative vasculopathy of the distal pulmonary circulation. Despite significant progress in our understanding of the pathophysiology, currently approved medical therapies for PAH act primarily as pulmonary...
Main Authors: | Robert Simmons Beck, Olin D. Liang, James R. Klinger |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-11-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2023.1274033/full |
Similar Items
-
SOX9 is a key component of RUNX2-regulated transcriptional circuitry in osteosarcoma
by: Young-Im Kim, et al.
Published: (2023-07-01) -
CircALMS1 Alleviates Pulmonary Microvascular Endothelial Cell Dysfunction in Pulmonary Hypertension
by: Xiaoyi Hu, et al.
Published: (2024-03-01) -
Mitochondrial dysfunction in pulmonary arterial hypertension
by: Weiwei Zhang, et al.
Published: (2022-12-01) -
Serum VEGF-A as a marker of endothelial dysfunction in children with acute lymphoblastic leukemia and pulmonary complications
by: N.I. Makieieva, et al.
Published: (2023-05-01) -
Platelets are indispensable for alveolar development in neonatal mice
by: Zilu Huang, et al.
Published: (2022-08-01)